Literature DB >> 10426813

Sex hormone-induced mammary carcinogenesis in female noble rats: the role of androgens.

B Xie1, S W Tsao, Y C Wong.   

Abstract

Breast cancer is the most common cancer and the second most frequent cause of cancer death in women. Despite extensive research, the precise mechanisms of breast carcinogenesis remain unclear. We have shown that in female rats, treatment with a combination of oestrogen and testosterone can induce a high incidence of mammary cancer. The dosage of testosterone affects only the latency period of mammary cancer, not the final incidence. Based on these observations, we hypothesize that oestrogen and androgens may act in concert on the mammary gland to induce mammary carcinogenesis, with oestrogen serving as the predominant initiator whereas the androgen acts as a major promoter. In the present study, we report the changes in morphology of the mammary gland with special emphasis on the perialveolar or interlobular stroma after treatment with various sex hormone protocols. Our data showed that after treatment with testosterone, either alone or in combination with 17beta-oestradiol, there was overexpression of the androgen receptor in alveolar or ductal epithelial cells. Concurrent with strong expression of the androgen receptor in epithelium, there was also an increase in the amount of perialveolar and interlobular connective tissue, a decrease in surrounding adipose tissue and an increase in proliferation rate of fibroblast-like cells in the stroma. All these changes were blocked by simultaneous implantation of flutamide, indicating that androgens play a crucial role in the process despite the absence of androgen receptors in stromal cells. We further measured the mammary gland density (MGD), in order to determine the ratio of fatty to non-fatty tissue. The data showed that MGD values were significantly higher in animals treated with testosterone alone or in combination with 17beta-oestradiol than in those treated with 17beta-oestradiol alone or in controls. Furthermore, treatment with different doses of testosterone resulted in an increase in MGD in a dose-dependent manner. These findings highlight the effect of androgens on the stroma, probably through a paracrine action of epithelial cells. The stroma may, in turn, promote mammary carcinogenesis in a reciprocal fashion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426813     DOI: 10.1093/carcin/20.8.1597

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

Review 1.  Targeting the androgen receptor in prostate and breast cancer: several new agents in development.

Authors:  Tracy Proverbs-Singh; Jarett L Feldman; Michael J Morris; Karen A Autio; Tiffany A Traina
Journal:  Endocr Relat Cancer       Date:  2015-02-26       Impact factor: 5.678

2.  Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model.

Authors:  Nur Ozten; Lori Horton; Salamia Lasano; Maarten C Bosland
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

3.  4-Vinylcyclohexene diepoxide (VCD) inhibits mammary epithelial differentiation and induces fibroadenoma formation in female Sprague Dawley rats.

Authors:  Laura E Wright; Jennifer B Frye; Ashley L Lukefahr; Samuel L Marion; Patricia B Hoyer; David G Besselsen; Janet L Funk
Journal:  Reprod Toxicol       Date:  2011-05-20       Impact factor: 3.143

Review 4.  Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland.

Authors:  T J Spady; R D McComb; J D Shull
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

5.  Clinicopathological study of breast tissue in female-to-male transsexuals.

Authors:  Hajime Kuroda; Kiyoshi Ohnisi; Goi Sakamoto; Shinji Itoyama
Journal:  Surg Today       Date:  2008-11-28       Impact factor: 2.549

6.  Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.

Authors:  G M Yousef; C A Borgoño; A Scorilas; R Ponzone; N Biglia; L Iskander; M-E Polymeris; R Roagna; P Sismondi; E P Diamandis
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

Review 7.  The role of androgens in experimental rodent mammary carcinogenesis.

Authors:  Jaesung Choi; Basil Psarommatis; Yan Ru Gao; Yu Zheng; David J Handelsman; Ulla Simanainen
Journal:  Breast Cancer Res       Date:  2014-11-25       Impact factor: 6.466

8.  Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor.

Authors:  Shuyuan Yeh; Yueh-Chiang Hu; Peng-Hui Wang; Chao Xie; Qingquan Xu; Meng-Yin Tsai; Zhihong Dong; Ruey-Sheng Wang; Ting-Hein Lee; Chawnshang Chang
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

9.  Steroid Tumor Environment in Male and Female Mice Model of Canine and Human Inflammatory Breast Cancer.

Authors:  Sara Caceres; Laura Peña; Gema Silvan; Maria J Illera; Wendy A Woodward; James M Reuben; Juan C Illera
Journal:  Biomed Res Int       Date:  2016-04-18       Impact factor: 3.411

10.  Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?

Authors:  Giuseppe Bronte; Sara Bravaccini; Sara Ravaioli; Maurizio Puccetti; Emanuela Scarpi; Daniele Andreis; Maria Maddalena Tumedei; Samanta Sarti; Lorenzo Cecconetto; Elisabetta Pietri; Valeria De Simone; Roberta Maltoni; Massimiliano Bonafè; Dino Amadori; Andrea Rocca
Journal:  Transl Oncol       Date:  2018-06-18       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.